CA2304267A1 - Aryloxymethyl carbapenem antibacterials - Google Patents

Aryloxymethyl carbapenem antibacterials Download PDF

Info

Publication number
CA2304267A1
CA2304267A1 CA002304267A CA2304267A CA2304267A1 CA 2304267 A1 CA2304267 A1 CA 2304267A1 CA 002304267 A CA002304267 A CA 002304267A CA 2304267 A CA2304267 A CA 2304267A CA 2304267 A1 CA2304267 A1 CA 2304267A1
Authority
CA
Canada
Prior art keywords
groups
substituted
unsubstituted
compound
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002304267A
Other languages
English (en)
French (fr)
Inventor
Frank P. Dininno
Helen Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9806433.0A external-priority patent/GB9806433D0/en
Application filed by Individual filed Critical Individual
Publication of CA2304267A1 publication Critical patent/CA2304267A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA002304267A 1997-09-17 1998-09-14 Aryloxymethyl carbapenem antibacterials Abandoned CA2304267A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5911197P 1997-09-17 1997-09-17
US60/059,111 1997-09-17
GBGB9806433.0A GB9806433D0 (en) 1998-03-25 1998-03-25 Carbapenem antibacterial compounds,compositions containing such compounds and methods of treatment
GB9806433.0 1998-03-25
PCT/US1998/019015 WO1999014217A1 (en) 1997-09-17 1998-09-14 Aryloxymethyl carbapenem antibacterials

Publications (1)

Publication Number Publication Date
CA2304267A1 true CA2304267A1 (en) 1999-03-25

Family

ID=26313360

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002304267A Abandoned CA2304267A1 (en) 1997-09-17 1998-09-14 Aryloxymethyl carbapenem antibacterials

Country Status (5)

Country Link
EP (1) EP1023293A4 (de)
JP (1) JP2002503638A (de)
AU (1) AU9774298A (de)
CA (1) CA2304267A1 (de)
WO (1) WO1999014217A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284753B2 (en) * 1998-06-02 2001-09-04 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US7632828B2 (en) * 2004-06-10 2009-12-15 Fob Synthesis, Inc. Gram-positive carbapenem antibacterials and processes for their preparation
CN106279178B (zh) * 2016-07-18 2019-01-18 华东理工大学 耐碳青霉烯类抗生素病菌的荧光探针及合成方法与应用
MX2023008677A (es) 2021-01-27 2023-10-03 Vandria Sa Derivados de urolitinas y métodos para su uso.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0467434A1 (de) * 1990-06-26 1992-01-22 Merck & Co. Inc. 2-Biphenyl-carbapeneme als antibakterielle Mittel
EP0464900A3 (en) * 1990-06-26 1992-07-22 Merck & Co. Inc. 2-biphenyl-carbapenems
US5132420A (en) * 1990-10-11 1992-07-21 Merck & Co., Inc. Intermediates for preparing 2-(substituted-dibenzo-furanyl and dibenzothienyl) carbapenem antibacterial agents
EP0695753A1 (de) * 1994-08-05 1996-02-07 Zeneca Limited Carbapenem-Derivate mit einem bicyclischen Substituenten, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
AU9774298A (en) 1999-04-05
JP2002503638A (ja) 2002-02-05
EP1023293A1 (de) 2000-08-02
EP1023293A4 (de) 2002-11-20
WO1999014217A1 (en) 1999-03-25

Similar Documents

Publication Publication Date Title
EP0906313B1 (de) Antibakterielle carbapenem-verbindungen, sie enthaltende zusammensetzungen undbehandlungsverfahren
CA2304267A1 (en) Aryloxymethyl carbapenem antibacterials
US6277843B1 (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US6284753B2 (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
AU732335B2 (en) 3-(iodophenoxymethyl) carbapenem antibacterials
US6288054B1 (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US6255300B1 (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US6346526B1 (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
AU732995B2 (en) Carbapenem antibacterial compounds, compositions and methods of treatment
AU4184497A (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US6207823B1 (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
EP1028962B1 (de) Antibakterielle carbapenem-verbindungen, zusammensetzungen, die diese verbindungen enthalten und behandlungsmethoden
AU734078B2 (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
AU4205499A (en) Naphthosulfamylmethyl penem antibacterials
CA2298997A1 (en) Carbapenems with naphthosultam derivative linked via methylene
AU4490597A (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
CA2335507A1 (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
AU1100399A (en) Antibacterial carbapenems, compositions and methods of treatmemt
JP2002518496A (ja) （複素環）メチル置換カルバペネムカルバペネム抗細菌物質
EP1089999A1 (de) Antibakterielle, heterozyklomethyl-substituierte carbapenem-verbindungen

Legal Events

Date Code Title Description
FZDE Dead